Remyelination in multiple sclerosis from the miRNA perspective

Remyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to...

Full description

Bibliographic Details
Main Authors: Karina Maciak, Angela Dziedzic, Joanna Saluk
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnmol.2023.1199313/full
_version_ 1797814372336140288
author Karina Maciak
Angela Dziedzic
Joanna Saluk
author_facet Karina Maciak
Angela Dziedzic
Joanna Saluk
author_sort Karina Maciak
collection DOAJ
description Remyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to nerve cell damage and progressive neurodegeneration. Stimulating the reconstruction of damaged myelin sheaths is one of the goals in terms of delaying the progression of MS symptoms and preventing neuronal damage. Short, noncoding RNA molecules, microRNAs (miRNAs), responsible for regulating gene expression, are believed to play a crucial role in the remyelination process. For example, studies showed that miR-223 promotes efficient activation and phagocytosis of myelin debris by microglia, which is necessary for the initiation of remyelination. Meanwhile, miR-124 promotes the return of activated microglia to the quiescent state, while miR-204 and miR-219 promote the differentiation of mature oligodendrocytes. Furthermore, miR-138, miR-145, and miR-338 have been shown to be involved in the synthesis and assembly of myelin proteins. Various delivery systems, including extracellular vesicles, hold promise as an efficient and non-invasive way for providing miRNAs to stimulate remyelination. This article summarizes the biology of remyelination as well as current challenges and strategies for miRNA molecules in potential diagnostic and therapeutic applications.
first_indexed 2024-03-13T08:06:44Z
format Article
id doaj.art-d845c5ee36114d5d86fe23465f45bef3
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-03-13T08:06:44Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-d845c5ee36114d5d86fe23465f45bef32023-06-01T04:57:34ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992023-06-011610.3389/fnmol.2023.11993131199313Remyelination in multiple sclerosis from the miRNA perspectiveKarina MaciakAngela DziedzicJoanna SalukRemyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to nerve cell damage and progressive neurodegeneration. Stimulating the reconstruction of damaged myelin sheaths is one of the goals in terms of delaying the progression of MS symptoms and preventing neuronal damage. Short, noncoding RNA molecules, microRNAs (miRNAs), responsible for regulating gene expression, are believed to play a crucial role in the remyelination process. For example, studies showed that miR-223 promotes efficient activation and phagocytosis of myelin debris by microglia, which is necessary for the initiation of remyelination. Meanwhile, miR-124 promotes the return of activated microglia to the quiescent state, while miR-204 and miR-219 promote the differentiation of mature oligodendrocytes. Furthermore, miR-138, miR-145, and miR-338 have been shown to be involved in the synthesis and assembly of myelin proteins. Various delivery systems, including extracellular vesicles, hold promise as an efficient and non-invasive way for providing miRNAs to stimulate remyelination. This article summarizes the biology of remyelination as well as current challenges and strategies for miRNA molecules in potential diagnostic and therapeutic applications.https://www.frontiersin.org/articles/10.3389/fnmol.2023.1199313/fullremyelinationmiRNAmicroRNAmultiple sclerosisoligodendrocytedemyelination
spellingShingle Karina Maciak
Angela Dziedzic
Joanna Saluk
Remyelination in multiple sclerosis from the miRNA perspective
Frontiers in Molecular Neuroscience
remyelination
miRNA
microRNA
multiple sclerosis
oligodendrocyte
demyelination
title Remyelination in multiple sclerosis from the miRNA perspective
title_full Remyelination in multiple sclerosis from the miRNA perspective
title_fullStr Remyelination in multiple sclerosis from the miRNA perspective
title_full_unstemmed Remyelination in multiple sclerosis from the miRNA perspective
title_short Remyelination in multiple sclerosis from the miRNA perspective
title_sort remyelination in multiple sclerosis from the mirna perspective
topic remyelination
miRNA
microRNA
multiple sclerosis
oligodendrocyte
demyelination
url https://www.frontiersin.org/articles/10.3389/fnmol.2023.1199313/full
work_keys_str_mv AT karinamaciak remyelinationinmultiplesclerosisfromthemirnaperspective
AT angeladziedzic remyelinationinmultiplesclerosisfromthemirnaperspective
AT joannasaluk remyelinationinmultiplesclerosisfromthemirnaperspective